#SabDimaagKaKhelHai

MISSION AND VISION

To enhance existing Drug therapies with Digital Therapeutics (DTx) to manage chronic conditions and
disorders by leveraging digital therapy, AI/ML, AR/VR, and IoT devices. Our data-driven approach aims to
develop generative AI models that offer clinically backed solutions to improve patients' quality of life,
increase treatment efficacy and provide data-driven insights. This hyper-personalized care need to be
validated through rigorous randomized controlled trials (RCTs).

THE IMPORTANCE
• Challenge with Drugs: Traditional pharmaceutical interventions often focus on symptom management or
disease modification. However, chronic conditions require a comprehensive approach that addresses
lifestyle factors, behavioral patterns, and patient engagement.
• DTx Contribution: Digital Therapeutics offers a holistic approach, combining behavioral interventions,
lifestyle modifications, and personalized care plans. By addressing various aspects of a patient's life, DTx
helps manage chronic conditions more comprehensively.
WHAT ? WHY? Current Solution?
Functional Gastrointestinal Disorders (FGIDs) are a pressing global health issue, affecting millions worldwide. These disorders,
including irritable bowel syndrome (IBS), functional dyspepsia, chronic constipation, chronic diarrhea and more.

Current solutions like Drug therapies and dietary interventions

Suffering due to FGID: often overlook the psychosomatic triggers caused by
• Social isolation and interpersonal challenges miscommunication between the gut and brain and fail to
• Work and productivity address the root cause of these triggers.
• Impact on mental health
• A diminished overall quality of life.
• Limited dietary options
• Financial burden

H T T P S :// W W W. G A S T R O J O U R N A L . O R G / A R T I C L E / S 0 0 1 6 - 5 0 8 5 ( 2 0 ) 3 0 4 8 7 - X / F U L LT E X T ? R E F E R R E R = H T T P S % 3 A % 2 F % 2 F W W W. T H E L A N C E T. C O M % 2 F
Healthcare Triad - Patient-Physician-Pharmaceutical

Constrain Faced by Gastroenterologist Patient Issues

• 30% of gastro visits involve FGID sufferers, resulting in • No long-term solution.
patient loss. • Poor QoL (ready to pay for solution).
• Consultation times for FGID patients are 2-3 times • No solution in Allopathy, Ayurvedic and
longer. Homeopathy
• Limited data to make right informed decisions. • Barrier to access comprehensive gastro care.
• Gut require comprehensive care due to their complexity.
• Patient education and adherence.
Challenges with Pharmaceutical Companies
• Low drug adoption under 50 yrs for chronic conditions due
to post-COVID awareness.
• Drugs act as suppressant in chronic/disorders.
• Less innovation & more generic.
• Drugs have side effects and long term safety concern.
 Solution
Our solution for FGID issues integrates Digital Therapeutics (DTx) with Drug therapy to focus on the often-overlooked gut-brain
interaction. By targeting cognitive, psychological, and behavioral factors, we enhance brain plasticity, balance the immune system, and
improve patients' quality of life. This data-driven, hyper-personalized approach empowers patients through education and comprehensive
disorder management, effectively addressing psychosomatic triggers and physiological symptoms.
Behavioral Experts provide
cognitive, psychological, and
Patient assessment behavioral interventions.

Personalized CBT
counselling Nutrition Expert provide low
FODMAP diets and food
Nutrition counselling Visit to Gastro Doc elimination and reintroduction
to rebalance the gut microbiome
Symptoms and trigger
management
DTx App, access to 3 Care manager oversee
Mindfulness training Experts delivering clinically relationships and managing all
validated protocol
processes.
Behavioral change Freemium Dashboard
counselling
RCT Data for Drug vs Drug+DTx Efficacy
Market Size & Target
Total Addressable Market (TAM)
01 Digital Therapeutic DTx global market was valued
around $6.5 B in 2022 and is projected to register 31.5%
CAGR between 2023 to 2032, says GMI.
Serviceable Addressable Market (SAM)
02 Healthcare app market size is around $ 1B in India
and out of which 15% is DTx app market share .

Serviceable Obtainable Market(SOM)

03 Considering 5 tier-1 cities(Delhi, Mumbai, Bangalore,
Hyderabad, Kolkata ) total (9.1 cr.) population out of
which practically considering 6% of population suffers
from IBS(54.6L) and converting 10% of patient reaching
via channels.(5.46L)*min. Onetime fee 10k( reach is
projected for 8 yrs)

$6.5 B
$1B

$65 M Location- India (initial 2-3 years), USA (After 2nd RCT and FDA approval as prescription DTx )
Age- 18+ to 50 years

https://www.gminsights.com/industry-analysis/digital-therapeutics-market
https://www.marketwatch.com/press-release/india-healthcare-apps-market-2023-rising-demand-emerging-growth-and-business-development-till-2030-2023-06-21?mod=search_headline
https://inkwoodresearch.com/reports/india-irritable-bowel-syndrome-treatment-market/
Competitors Bold Health Mindset Cara Care WinHealth Mahana DailyBloom-
Benefits
Health by Dr. Reddy

Nutrition
analysis
Activity
tracking
FODMAP Diet

Behavioral Self Assist CBT Self manage IBS Self manage Personalised 1:1 Self Assist CBT Yoga,
Approach modules via pre-recorded IBS via pre- Integrated modules Meditation &
specialised for Hypnotherapy. recorded Psychology specialised for breathing
IBS. Hypnotherapy. sessions. IBS. techniques for
IBS
Dashboard for
hospital/docto
rs (Freemium)
Behavioral +
Food Science

IoT devices

Clinically
Validated DTx
protocol
Price INR 67600 / INR 20,000 / INR 75,000 / INR 36,000 / INR 64,000 / INR 12,000/3
Year Year Year 6months + Year Year months
Business & Revenue
Current Development
The Investment
• Valuation: Company valued at INR 16 Cr Compliance & Certification
• Ask: INR 2.5 Cr against CCPS or Equity. 5%
• Equity : Dilution in range of 15-16%

Clinical Trails and International Approval Operational Cost (DTx & BD Team)
35% 25%

PR, Marketing and Seminars

10% Product Development (Tech Team)
25%
Meet the Team
C EO, S H AS H A N K M I S H R A HEAD OF NUTRITION, SINDHU HS
IIIT Alumni, 2x founder: MicroHeal Wellness & Elixir- The MS in Food & Nutrition, Reg. Clinical Nutritionist.
Health Café, 9+ yrs exp. Ex-Consultant at BHGE, PDO. Practicing. 12+ yrs of exp. Ex- Navipoint Health &
Truworth.

C B O, H A R S H A N K PA R AS H A R P S Y C H O L O G I S T, M S . P O N U G O T I
VA I S H N AV I D E V I
IIIT Alumni, 8+ years exp. in Business development, Masters in Psychology from GITAM University, 4 yrs of
Revenue modeling, Startup operations. Ex-BYJU'S, TechXR experience in Psychology field. Psychodiagnostics and
psychological from Tomsk State university.

H E A D O F P S Y C H O . D R . D E E P A K S A LV I T EC H N O LO GY L E A D, S A M B I T M A J H I

Ph.D. in Clinical Psychology, NIMHANS Alumni, 13+ years of 4+ years of product building experience, B.Tech, KiiT
experience. RCI registered Behavioral Science, CBT expert. University, Full stack developer
Our Advisors
B H A R AT S . P AT E L , T E C H N O L O G Y
GUNJAN JAIN, ENTREPRENEUR(DTX)
S T R AT E G I S T
IIT-B, Alumni, 20 years of experience in Healthtech industry. CEO Chairman and Director at Yudiz Solutions,
& Director, Medily Prime, Ex-CEO Tatva Care, a Zydus company. Director at Fetuz Hatcher and Mentored 7 Startup Companies t
Startup Advisor/Mentor. Soar High in Hardware and Software Industry.

D R . J AT I N Y E G U R L A , D M ( G A S T R O) D R . VA R U N A G G A R WA L , M I C R O B I O M E
EXPERT
9 years of extensive experience to his practice at Apollo Hospitals Assistant Professor and Principal Investigator of the
Jubilee Hills in Hyderabad. MBBS from Osmania, MD from PGIMER Microbiome Therapeutics laboratory at the Jio
Chandigarh, DM from AIIMS New Delhi (Topper), FAGIE from AIIMS Institute. Doctoral research at the Perelman School of
New Delhi, and ESEGH from London, UK. Medicine of University of Pennsylvania, focusing on
problems related to personalized medicine and genetics
Supported and Backed by -

And more………..

Questions? Let’s get talking.

Contact

E-MAIL ADDRESS PHONE

[email protected] Ahmedabad, Gujarat, IN +91 7376113646

[email protected]
Global Market & Reimbursement trends
Global DTx Solution & their Pathway